Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC.LXRX · Entity 4970 | SVP, General Counsel & Secr. | February 28, 2026 | March 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LEXICON PHARMACEUTICALS, INC.
Report date February 28, 2026 · Filed March 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 363,658 |
Reported balance
After 2026-02-28 transaction · row 1
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 1 · 2026-02-28 · Exercise / conversion · Acquired 33,457 · Balance 363,658 F1: Each restricted stock unit represents a contingent right to receive one share of common stock. |
| Common StockSEC Table I · non-derivative | Direct | 330,201 |
Reported balance
After 2026-02-28 transaction · row 2
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 2 · 2026-02-28 · Exercise / conversion · Acquired 69,386 · Balance 330,201 F1: Each restricted stock unit represents a contingent right to receive one share of common stock. |
| Common StockSEC Table I · non-derivative | Direct | 533,821 |
Reported balance
After 2026-02-28 transaction · row 3
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 3 · 2026-02-28 · Exercise / conversion · Acquired 170,163 · Balance 533,821 F1: Each restricted stock unit represents a contingent right to receive one share of common stock. |
| Common StockSEC Table I · non-derivative | Direct | 428,802 |
Reported balance
After 2026-02-28 transaction · row 4
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 4 · 2026-02-28 · Tax withholding · Disposed 105,019 · Balance 428,802 F2: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 69,387 |
Reported balance
After 2026-02-28 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-02-28 · Exercise / conversion · Disposed 69,386 · Balance 69,387 F1: Each restricted stock unit represents a contingent right to receive one share of common stock. F3: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-02-28 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-02-28 · Exercise / conversion · Disposed 33,457 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of common stock. F3: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 340,327 |
Reported balance
After 2026-02-28 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-02-28 · Exercise / conversion · Disposed 170,163 · Balance 340,327 F1: Each restricted stock unit represents a contingent right to receive one share of common stock. F3: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of common stock.
F2: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
F3: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 28, 2021 Filed Mar 2, 2021 21:57 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 21,030 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-008770 · form4.xml · nonDerivative · entry 4 Crum Brian T · CIK 0001792747 · VP, General Counsel & Secr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,497 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 21:57 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 11,100 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-008770 · form4.xml · nonDerivative · entry 3 Crum Brian T · CIK 0001792747 · VP, General Counsel & Secr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,467 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 21:57 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 5,118 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-008770 · form4.xml · nonDerivative · entry 2 Crum Brian T · CIK 0001792747 · VP, General Counsel & Secr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,367 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 21:57 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 1,517 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-008770 · form4.xml · nonDerivative · entry 1 Crum Brian T · CIK 0001792747 · VP, General Counsel & Secr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,249 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 11, 2021 Filed Feb 16, 2021 21:13 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 78,760 | $0.00 Strike: $8.38 | $0.00 |
DisclosureSEC source: 0001127602-21-005835 · form4.xml · derivative · entry 2 Crum Brian T · CIK 0001792747 · VP, General Counsel & Secr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,760 Underlying: Common Stock · 78,760 shares Expires 2031-02-11 F3 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 11, 2021 Filed Feb 16, 2021 21:13 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 26,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005835 · form4.xml · derivative · entry 1 Crum Brian T · CIK 0001792747 · VP, General Counsel & Secr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,250 Underlying: Common Stock · 26,250 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F2 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| April 22, 2020 Filed Apr 24, 2020 21:05 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Tax withholdingCommon Stock | 6,398 | $1.96 | $12,540.08 |
DisclosureSEC source: 0001127602-20-014489 · form4.xml · nonDerivative · entry 2 Crum Brian T · CIK 0001792747 · VP, General Counsel & Secr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,732 F2 · kind: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Read SEC document |
| April 22, 2020 Filed Apr 24, 2020 21:05 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantCommon Stock | 19,893 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-014489 · form4.xml · nonDerivative · entry 1 Crum Brian T · CIK 0001792747 · VP, General Counsel & Secr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,130 F1 · kind: Issued upon vesting of performance-based restricted stock units granted on December 5, 2019, the vesting of which was determined by the compensation committee in its sole discretion based on pre-specified corporate goals. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:12 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 11,100 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-008951 · form4.xml · derivative · entry 9 Crum Brian T · CIK 0001792747 · VP, General Counsel & Secr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,200 Underlying: Common Stock · 11,100 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F6 · derivative.exercise_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter. F6 · derivative.expiration_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:12 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 5,119 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-008951 · form4.xml · derivative · entry 8 Crum Brian T · CIK 0001792747 · VP, General Counsel & Secr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,118 Underlying: Common Stock · 5,119 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F5 · derivative.exercise_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2019 and vest an additional one third on February 28 of each of the two succeeding years thereafter. F5 · derivative.expiration_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2019 and vest an additional one third on February 28 of each of the two succeeding years thereafter. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:12 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 1,518 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-008951 · form4.xml · derivative · entry 7 Crum Brian T · CIK 0001792747 · VP, General Counsel & Secr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,517 Underlying: Common Stock · 1,518 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F4 · derivative.exercise_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. F4 · derivative.expiration_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:12 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 2,515 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-008951 · form4.xml · derivative · entry 6 Crum Brian T · CIK 0001792747 · VP, General Counsel & Secr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,515 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2017 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. F3 · derivative.expiration_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2017 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:12 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Tax withholdingCommon Stock | 6,940 | $2.77 | $19,223.80 |
DisclosureSEC source: 0001127602-20-008951 · form4.xml · nonDerivative · entry 5 Crum Brian T · CIK 0001792747 · VP, General Counsel & Secr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,237 F2 · kind: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:12 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 11,100 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-008951 · form4.xml · nonDerivative · entry 4 Crum Brian T · CIK 0001792747 · VP, General Counsel & Secr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,177 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:12 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 5,119 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-008951 · form4.xml · nonDerivative · entry 3 Crum Brian T · CIK 0001792747 · VP, General Counsel & Secr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,077 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:12 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 1,518 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-008951 · form4.xml · nonDerivative · entry 2 Crum Brian T · CIK 0001792747 · VP, General Counsel & Secr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,958 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:12 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 2,515 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-008951 · form4.xml · nonDerivative · entry 1 Crum Brian T · CIK 0001792747 · VP, General Counsel & Secr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,440 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 21:10 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 189,260 | $0.00 Strike: $3.31 | $0.00 |
DisclosureSEC source: 0001127602-20-004595 · form4.xml · derivative · entry 2 Crum Brian T · CIK 0001792747 · VP, General Counsel & Secr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,260 Underlying: Common Stock · 189,260 shares Expires 2030-02-06 F3 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 21:10 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 63,090 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-004595 · form4.xml · derivative · entry 1 Crum Brian T · CIK 0001792747 · VP, General Counsel & Secr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,090 Underlying: Common Stock · 63,090 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F2 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.